Also known as آسٹیوپوروسس مینجمنٹ
Internal Medicine Specialist
M.B.B.S., F.C.P.S ( Medicine)
Gastroenterologist
M.B.B.S , F.C.P.S
Gastroenterologist
M.B.B.S., M.C.P.S, F.C.P.S., M.R.C.P
Diabetologist
M.D (St'Lucia), Diplomate Diabetes
Gastroenterologist
M.B.B.S., F.C.P.S., MACG (America), Certification Harward Medical School (America ), Certification Royal College of Physician(UK)
Gastroenterologist
M.B.B.S., F.C.P.S., MACG (America), Certification Harward Medical School (America ), Certification Royal College of Physician(UK)
Internal Medicine Specialist
M.B.B.S, F.C.P.S (Medicine)
Internal Medicine Specialist
M.B.B.S., F.C.P.S.
Diabetologist
M.B.B.S, P.G Diabetes, M.Sc Diabetes
Diabetologist
M.B.B.S., M.M.C.H (Pediatrics), PGD Nutrition, Dip. in Diabetes (DMC)
Diabetologist
M.B.B.S., M.M.C.H (Pediatrics), PGD Nutrition, Dip. in Diabetes (DMC)
Internal Medicine Specialist
M.B.B.S., F.C.P.S.
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures